Positive Trend of Stocks: Mid-Con Energy Partners, LP (NASDAQ:MCEP), PowerSecure International, Inc. (NYSE:POWR), PDL BioPharma, Inc. (NASDAQ:PDLI),

Mid-Con Energy Partners LP(NASDAQ:MCEP) aims to use the net proceeds of this offering, after deducting underwriting discounts and estimated expenses, to fund a portion of the purchase price of its previously announced pending acquisition of the Eastern Shelf properties in the Permian Basin in West Texas. Mid-Con Energy Partners, LP (NASDAQ:MCEP) Trend Analysis stock hit highest price at $16.92, beginning with a price of $16.80 to the closed at 16.45 by a loss of -8.56% with a day range of $16.33-$16.92. The total market capitalization remained 347.6 Million, total volume of 1.86 Million shares held in the session was surprisingly higher than its average volume of 119.74 shares.PowerSecure International, Inc.(NYSE:POWR) reported that it has strengthened and realigned its leadership team to surge efficiency, enhance profitability and drive operational excellence, as the firm is positioned for significant possible revenue growth in 2015 as well as the coming years. As division of this leadership initiative, Chris Hutter, PowerSecure's CFO for the past seven years, will remain with PowerSecure and transition to the newly created role of chief operating officer On the other consideration, PowerSecure International, Inc. (NYSE:POWR) Trend Analysis begun last trade with a price of $11.16 and throughout the trading session climbed at $11.22. The day-trade ended with a loss of -2.42% to closed at $10.89. The stock is going forward its fifty-two week low with 69.89% and lagging behind from its 52 week high price with -60.31%. POWR last month stock price volatility remained 5.51%.PDL BioPharma Inc(NASDAQ:PDLI) annonced that its third quarter earnings of $0.61 a share, $0.06 imrpoved than the Capital IQ Consensus Estimate of $0.55; revenues rose 64.3% year/year to $164.6M as compared to the $163.69M consensus. Net cash provided by operating activities in the first nine months of 2014 was $223.2 million, compared with $208.5 million in the first nine months of 2013. Shares of PDL BioPharma, Inc. (NASDAQ:PDLI) Trend Analysis opened at $8.00 with 160.64 million outstanding shares and hit to its highest price of $8.289 during the day and finally closed at $8.11 by scoring 2.27%. In the whole session, it traded on volume of 3.51 Million shares, which turned higher than its average volume.